402 related articles for article (PubMed ID: 29775599)
1. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
[TBL] [Abstract][Full Text] [Related]
3. Validation of the ENDPAC model: Identifying new-onset diabetics at risk of pancreatic cancer.
Khan S; Safarudin RF; Kupec JT
Pancreatology; 2021 Apr; 21(3):550-555. PubMed ID: 33583686
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
5. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age.
Mizuno S; Nakai Y; Isayama H; Yanai A; Takahara N; Miyabayashi K; Yamamoto K; Kawakubo K; Mohri D; Kogure H; Sasaki T; Yamamoto N; Sasahira N; Hirano K; Tsujino T; Ijichi H; Tateishi K; Akanuma M; Tada M; Koike K
J Gastroenterol; 2013 Feb; 48(2):238-46. PubMed ID: 22735942
[TBL] [Abstract][Full Text] [Related]
7. Two different types of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer.
Tanţău A; Negrean V; Alexescu T; Para I; Tărmure S; Casoinic F; Sâmpelean D; Mocanu T; Tanţău M
Rom J Intern Med; 2014; 52(1):18-23. PubMed ID: 25000673
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters.
Cichosz SL; Jensen MH; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
Comput Methods Programs Biomed; 2024 Feb; 244():107965. PubMed ID: 38070389
[TBL] [Abstract][Full Text] [Related]
9. Effect of glycemic control on the risk of pancreatic cancer: A nationwide cohort study.
Er KC; Hsu CY; Lee YK; Huang MY; Su YC
Medicine (Baltimore); 2016 Jun; 95(24):e3921. PubMed ID: 27311001
[TBL] [Abstract][Full Text] [Related]
10. Derivation and validation of diabetes risk score for urban Asian Indians.
Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
[TBL] [Abstract][Full Text] [Related]
11. Probability of pancreatic cancer following diabetes: a population-based study.
Chari ST; Leibson CL; Rabe KG; Ransom J; de Andrade M; Petersen GM
Gastroenterology; 2005 Aug; 129(2):504-11. PubMed ID: 16083707
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
Ritchie SA; Chitou B; Zheng Q; Jayasinghe D; Jin W; Mochizuki A; Goodenowe DB
World J Gastroenterol; 2015 Jun; 21(21):6604-12. PubMed ID: 26074698
[TBL] [Abstract][Full Text] [Related]
13. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
14. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
Chari ST; Maitra A; Matrisian LM; Shrader EE; Wu BU; Kambadakone A; Zhao YQ; Kenner B; Rinaudo JAS; Srivastava S; Huang Y; Feng Z;
Contemp Clin Trials; 2022 Feb; 113():106659. PubMed ID: 34954100
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
Khan S; Al Heraki S; Kupec JT
Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the END-PAC Model in Predicting the Risk of Developing Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis.
Hajibandeh S; Intrator C; Carrington-Windo E; James R; Hughes I; Hajibandeh S; Satyadas T
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002040
[TBL] [Abstract][Full Text] [Related]
17. Diabetes Mellitus in the Middle-Aged and Elderly Population (>45 Years) and Its Association With Pancreatic Cancer: An Updated Review.
Kaleru T; Vankeshwaram VK; Maheshwary A; Mohite D; Khan S
Cureus; 2020 Jun; 12(6):e8884. PubMed ID: 32742851
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer.
Dong X; Lou YB; Mu YC; Kang MX; Wu YL
Digestion; 2018; 98(4):209-216. PubMed ID: 30045045
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
McWilliams RR; Maisonneuve P; Bamlet WR; Petersen GM; Li D; Risch HA; Yu H; Fontham ET; Luckett B; Bosetti C; Negri E; La Vecchia C; Talamini R; Bueno de Mesquita HB; Bracci P; Gallinger S; Neale RE; Lowenfels AB
Pancreas; 2016 Feb; 45(2):311-6. PubMed ID: 26646264
[TBL] [Abstract][Full Text] [Related]
20. New-onset diabetes in pancreatic cancer: a study in the primary care setting.
Aggarwal G; Rabe KG; Petersen GM; Chari ST
Pancreatology; 2012; 12(2):156-61. PubMed ID: 22487526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
